Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Dutasteride and finasteride affect different cell types differently.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Certain natural compounds called terpenes may help prevent prostate cancer.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Mutations in certain receptors can cause diseases and offer new treatment options.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.